Fenwick & West represented Formation Bio in the transaction, and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Thrive Capital. Formation Bio, a NYC-based tech-driven and...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Wonder in the transaction. Wonder announced it has completed $700 million financing that included existing investors NEA, GV, Accel, Bain Capital Ventures, Forerunner,...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Lightspeed Ventures in the transaction. Vestwell announced it has raised $125 million in Series D financing round led by Lightspeed, with participation from Fin...
You must be a Standard 1 Year member to access this content.
Fenwick & West is representing Databricks Inc. in the transaction. Databricks Inc. announced its acquisition of Arcion, a Databricks Ventures portfolio company. The transaction will allow Databricks to...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Machina Labs in the transaction. Machina Labs announced its $32 million Series B financing. The round was co-led by new investor NVentures, NVIDIA’s...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented Postscript in the transaction. The leading SMS marketing platform for ecommerce companies, Postscript announced it has acquired Fondue a developer of a...
You must be a Standard 1 Year member to access this content.
Fenwick represented Abdera Therapeutics on the deal. Abdera Therapeutics, a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Tekion on the deal. Tekion, a cloud-based automotive software provider, announced its $250 million Series D financing, valuing the company at $3.5 billion....
You must be a Standard 1 Year member to access this content.
Fenwick & West advised TrialSpark on the deal. TrialSpark, a technology-driven pharma company that runs end-to-end clinical trials, announced its $156 million Series C financing. The round...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Redfin Corporation on the deal. Redfin Corporation (NASDAQ: RDFN), a technology-powered real estate broker, instant home-buyer, lender, title insurer and renovations...
You must be a Standard 1 Year member to access this content.
